• BG IRIS Research Client Login
logo
logo
  • Transactions
  • Services
    • Overview
    • Solutions
    • Sector expertise
    • Research
  • Insights
    • Overview
    • White Papers
    • Blog
    • Reports
    • Client Focus
  • About us
    • Overview
    • Senior Team
    • News
    • Events
  • Careers
    • Overview
    • Early careers
    • Experienced hires
    • Employee Growth Stories
  • Media
    • Press
    • Videos
  • Contact
  • Search
  • BG IRIS Research Client Login

Solutions


From raising venture capital to taking companies public, supporting acquisition strategies to advising management buy-outs or finding strategic partners, Bryan Garnier supports clients and their investors at every stage of their growth and investing journeys.​ Bryan Garnier’s holistic approach to advising clients on the full range of equity, debt and M&A transactions creates a true client-first model, building long-term relationships over the full business lifecycle.

M&A Advisory


Private Capital Solutions


Debt Solutions

Public Capital Solutions


Institutional Sales and Trading

Hide filtersShow filters
× Close

Sectors

  • (218)
  • (177)
  • (106)
  • (96)
  • (48)

Deal Type

  • (298)
  • (141)
  • (141)
  • (7)

Clear all Apply

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner for Medartis’ IPO CHF142.6 million on SIX Swiss Exchange

Medartis tombstone

Bryan, Garnier & Co part of bulge bracket syndicate for DBV $150 million Follow-on

DBV tombstone

Bryan, Garnier & Co advises Bone Therapeutics on its €19.45 million convertible bond placement

Bone Therapeutics tombstone

Bryan Garnier & Co acts as Global Coordinator for Biom’Up’s financing representing a total amount of more than €40 million

BiomUp tombstone

Bryan, Garnier & Co acts as Co-manager for Ablynx Nasdaq IPO raising USD 230 million

Ablynx tombstone

Bryan Garnier & Co acts as Sole Global Coordinator for Biom’Up’s landmark Euronext IPO, raising up to €44 million including greenshoe

BiomUp_Oct_17 tombstone

Bryan, Garnier & Co acts as Joint Bookrunner of a private placement with US and European Investors raising €18 Million for Oryzon

Oryzon tombstone

Upon pricing its landmark IPO on Euronext Paris led by Sole Global Coordinator Bryan, Garnier & Co, Symetis is acquired by Boston Scientific for USD 435 million

Symetis tombstone

Bryan, Garnier & Co announces the successful USD 22 million / DKK 143 million follow-on offering for Zealand Pharma

Zealand tombstone

Bryan, Garnier & Co annouces the successful closing of Soitec’s €75.4 million Rights Issue

Soitec tombstone

Rights Issue Sandnes Sparebank ASA

Sandes Sparebank_jun16

Bryan, Garnier & Co announces a €14.7m follow-on offering for Amoeba on Euronext with demand from European and US investors

Amoeba tombstone
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 12

Bryan, Garnier & Co

Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors.

CONTACT US
Latest News

  • BCI – Made in France 2025 – Hosted by Bryan, Garnier & Co
  • The Next Launch Window: What It Means for Satcoms
  • BG Growth Series – Avantium
  • Energy-Aware AI: Confronting the power-hungry reality of scaling AI
Quick links

Transactions

Insights

Senior Team

Information

Legal & Regulatory Information

Index 2025

Bryan Garnier Securities

Privacy Policy

Privacy Preference Center

Privacy Preferences

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }